Results

Total Results: 2,181 records

Showing results for "harms".

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-236-mental-health-pregnancy-evidence-summary.pdf
    April 01, 2021 - • The paucity of evidence does not mean that pharmacotherapy is not beneficial, nor that harms do … ; a systematic review will help clarify the balance of benefits and harms. … As a result, most studies could not assert a causal relationship between exposure and resultant harms … Regarding maternal harms, benzodiazepine before conception may be associated with an increased risk … By contrast, evidence is voluminous but of low quality on the harms of pharmacotherapy.
  2. effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-patients-with-insomnia-how-do-commonly-used-medications-compare-for-effectiveness-and-harms-including-addictive-potential
    November 01, 2017 - For patients with insomnia, how do commonly used medications compare for effectiveness and harms … For patients with insomnia, how do commonly used medications compare for effectiveness and harms … For patients with insomnia, how do commonly used medications compare for effectiveness and harms, including … quality of life, sleep quality, fatigue Describe any health-related risks, side effects, or harms … For patients with insomnia, how do commonly used medications compare for effectiveness and harms
  3. S23 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/s23.pdf
    October 01, 2007 - of atypical antipsychotics.21 The review summarized 5 RCTs that discussed harms. … Asymmetric Communication of Benefits and Harms Benefits may be presented in relative terms but harms … for both benefits and harms. … for harms). … benefits, and 11% reported only harms.
  4. effectivehealthcare-admin.ahrq.gov/products/diagnostic-errors-emergency/protocol
    February 01, 2021 - , and serious misdiagnosis-related harms?  … serious misdiagnosis-related harms?  … , and serious misdiagnosis-related harms Frequency of diagnostic errors, misdiagnosis-related harmsharms, and serious misdiagnosis-related harms overall and for key clinical conditions (KQ2) Patient … †Misdiagnosis-related harms are defined as harms resulting from the delay or failure to treat a condition
  5. effectivehealthcare-admin.ahrq.gov/products/genitourinary-syndrome/research
    March 01, 2025 - Key Question 3: What are the harms (and comparative harms) of hormonal, non-hormonal, and energy-based … to evaluate infrequent but serious harms though most studies did not report frequent serious harms. … This was particularly noticeable in harms reporting; definitions and reporting of harms/adverse effects … frequent serious harms. … but serious harms, though most studies did not report frequent serious harms.
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND-0651-131114.pdf
    June 20, 2013 - The nominator is also interested in the harms and benefits of the treatment options. … In patients with low back pain, what are the benefits and harms of identifying risk from Nominator: … What are the comparative benefits and harms of different pharmacological therapies for radicular low … What are the comparative benefits and harms of different non-pharmacological, non-invasive therapies … What are the comparative benefits and harms of combinations of therapies (versus single therapies or
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/patient-safety-practices-rapid-protocol.pdf
    September 09, 2022 - Potential Harms Resulting from Patient-Clinician Real-Time Clinical Encounters using Video-based Telehealth … Review Evidence-based Practice Center Rapid Review Protocol Project Title: Potential Harms … What is the frequency and severity of harms associated with use of telehealth in real-time clinical … What patient safety measures or patient safety indicators have been used to examine the harms associated … What patient safety practices have been used to prevent or mitigate the harms associated with use of
  8. effectivehealthcare-admin.ahrq.gov/products/patient-safety-telehealth/protocol
    July 01, 2023 - Home Evidence Reports Making Healthcare Safer IV: Potential Harms … SHARE: Making Healthcare Safer IV: Potential Harms … Review Questions What is the frequency and severity of harms associated with use … What patient safety measures or patient safety indicators have been used to examine the harms associated … What patient safety practices have been used to prevent or mitigate the harms associated with use of
  9. effectivehealthcare-admin.ahrq.gov/products/hypothyroidism-hyperthyroidism-screening-treatment/research
    December 01, 2019 - What are the harms of screening for subclinical thyroid dysfunction? … and treatment benefits and harms. … Since 2002, no studies have directly assessed the benefits or harms of screening. … Treatment harms were neither systematically evaluated nor well described. … the harms of treatment.
  10. effectivehealthcare-admin.ahrq.gov/products/chronic-urinary-retention/research
    December 01, 2019 - Evidence Reports Chronic Urinary Retention: Comparative Effectiveness and Harms … SHARE: Chronic Urinary Retention: Comparative Effectiveness and Harms … Evidence on harms was inconsistently reported across all interventions, and no differences were detected … across treatment groups; however, studies were not adequately powered to detect differences in harms … Project Timeline Chronic Urinary Retention: Comparative Effectiveness and Harms of Treatments Oct
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-218-osteoporosis-disposition-comments.pdf
    April 23, 2019 - as class- specific harms for DMB. … , and Technical Expert Panel harms research priorities. … benefit/”harms” discussion. … treatments with these harms separately. … Most of the information in the draft report on harms, particularly on rare harms, was from observational
  12. effectivehealthcare-admin.ahrq.gov/products/infantile-hemangioma/research
    December 01, 2019 - Review methods We included comparative studies of interventions, case series addressing harms, and … Steroid harms frequently included Cushingoid facies, irritability/mood changes, and growth retardation … Laser treatment harms included hypopigmentation and scarring. … Beta-blockers and steroids also may cause clinically important harms (moderate SOE for association of … oral propranolol with harms).
  13. effectivehealthcare-admin.ahrq.gov/products/major-depressive-disorder/research
    December 01, 2019 - Structured Abstract Objective To compare the benefits and harms of second-generation antidepressants … For risk of harms, we graded the strength of evidence as moderate for some outcomes of three comparisons … Our confidence in the benefits and harms of SGAs compared with the remaining treatment options is low … Comparative Benefits and Harms of Antidepressant, Psychological, Complementary, and Exercise Treatments … Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
    September 01, 2020 - prostatectomy (RP) may reduce mortality and metastases more than watchful waiting (WW) but causes more harmsHarms were lowest with AM compared with RP or EBR plus AD or AS versus photodynamic therapy. … Associated harms were unclear. … Harms are greater with RP. AM was compared with RP or EBR plus AD in PSA screen–detected CLPC. … However, it may also result in an increase in harms.
  15. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain_executive.pdf
    October 01, 2011 - Key Question Strength of Evidence Conclusion GI and CV harms: Celecoxib High for GI harms vs. nonselective … GI and CV harms: Partially selective NSAIDs GI harms: Moderate for meloxicam and etodolac (fewer trials … GI and CV harms: Nonselective NSAIDs GI harms: High for naproxen, ibuprofen, and diclofenac (consistent … Key Question Strength of Evidence Conclusion GI and CV harms: Nonselective NSAIDs (continued) CV harms … GI and CV harms: Aspirin Moderate for GI and CV harms (many trials, but almost exclusively in patients
  16. effectivehealthcare-admin.ahrq.gov/products/osteoporosis-fracture-prevention/research
    January 01, 2020 - Long-term oral hormone therapies reduce hip and clinical fractures but increase multiple serious harms … Trials were used for incident fractures and harms, and controlled observational studies were included … for additional harms. … Harms and controls were inconsistently defined. Conclusions. … Evidence is limited regarding ODT holidays for fractures and harms.
  17. effectivehealthcare-admin.ahrq.gov/products/headaches-pregnancy/research
    June 01, 2022 - A single primary study provided insufficient (direct) evidence to make conclusions about the harms of … ; fetal/child harms were not reported. … Our a priori approach to examining harms of relevant medications in this review was restricted to harms … can cause some of the harms, irrespective of exposure to interventions. … of indication, some well-accepted harms of treatment were not addressed.
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_executive.pdf
    May 01, 2013 - They were included for the assessment of harms if they reported on harms of treatments for which data … (continued) Harms: Local Wound Applications Dressings and topical therapies Moderate Harms reported … harms by ulcer characteristics. … harms by patient characteristics. … harms by patient care setting.
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND__0250_05-20-2010.pdf
    January 01, 2010 - What are the benefits and harms of rhythm control compared to rate control (including newer agents)? … What are the benefits and harms of strict versus more lenient rate control? 2. … What are the benefits and harms of different anticoagulation and antiplatelet agents and monitoring … What are the benefits and harms of antiarrhythmic agents for acute conversion of AF to sinus rhythm … What are the benefits and harms of ACEIs, ARBs and statins in the prevention of new AF and progression
  20. effectivehealthcare-admin.ahrq.gov/products/collections/making-healthcare-safer-IV
    January 01, 2025 - COLLECTION February 6, 2024 A Continuous Updating of Patient Safety Harms … Potential Harms Resulting From Patient- Clinician Real-Time Clinical Encounters Using Video-Based Telehealth … Reducing Adverse Drug Events Related to Anticoagulant Use in Adults Deprescribing To Reduce Medication Harms … of Service Rapid Evidence Product | Sep 14, 2023 Making Healthcare Safer IV: Potential Harms … Anticoagulant Use in Adults Rapid Evidence Product | Feb 1, 2024 Deprescribing To Reduce Medication Harms

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: